New gel injection could ease arthritic knees
NCT ID NCT07516457
First seen Jun 26, 2026 · Last updated Jul 15, 2026 · Updated 3 times
Summary
This study tests a single injection of Hydrogel OA 2% in 20 adults with knee osteoarthritis. The goal is to see if the gel is safe and tolerable over 13 weeks to 12 months. Participants must be 35–75 years old with a BMI between 20 and 35.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hydrogel OA 2%
- What this could lead to
- If it works, this could provide a safe, single-injection option to ease knee osteoarthritis pain and improve joint function.
- What could go wrong
- This is a very small, early safety study with only 20 participants. It does not yet measure effectiveness, and the gel may not reduce pain or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEO ARTHRITIS OF THE KNEE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AZ Delta
Roeselare, Belgium
-
AZ Monica
Deurne, Belgium
-
AZ Sint Jan
Bruges, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smaller cut in robotic knee surgery mean less pain and faster healing?
- One shot, one year: could a single injection ease knee arthritis pain?
- Can hip exercises protect knee cartilage in osteoarthritis?
- Robotic vs. manual knee alignment: which is better for heavier patients?
- Laser treatment shows promise for easing knee arthritis pain
- New knee injection polymer put to the test in first human trial